- Home
- BDTX vs PROF Comparison
BDTX vs PROF Comparison
Compare BDTX & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- PROF
- Stock Information
- Founded
- BDTX 2014
- PROF N/A
- Country
- BDTX United States
- PROF Canada
- Employees
- BDTX N/A
- PROF N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- PROF Medical/Dental Instruments
- Sector
- BDTX Health Care
- PROF Health Care
- Exchange
- BDTX Nasdaq
- PROF Nasdaq
- Market Cap
- BDTX 132.5M
- PROF 149.7M
- IPO Year
- BDTX 2020
- PROF N/A
- Fundamental
- Price
- BDTX $2.58
- PROF $5.98
- Analyst Decision
- BDTX Strong Buy
- PROF Strong Buy
- Analyst Count
- BDTX 6
- PROF 2
- Target Price
- BDTX $14.83
- PROF $11.50
- AVG Volume (30 Days)
- BDTX 1.3M
- PROF 40.7K
- Earning Date
- BDTX 08-05-2025
- PROF 08-07-2025
- Dividend Yield
- BDTX N/A
- PROF N/A
- EPS Growth
- BDTX N/A
- PROF N/A
- EPS
- BDTX 0.09
- PROF N/A
- Revenue
- BDTX $70,000,000.00
- PROF $11,862,000.00
- Revenue This Year
- BDTX N/A
- PROF $71.17
- Revenue Next Year
- BDTX N/A
- PROF $134.25
- P/E Ratio
- BDTX $29.29
- PROF N/A
- Revenue Growth
- BDTX N/A
- PROF 75.01
- 52 Week Low
- BDTX $1.20
- PROF $3.90
- 52 Week High
- BDTX $6.75
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- BDTX 60.64
- PROF 50.62
- Support Level
- BDTX $2.43
- PROF $5.84
- Resistance Level
- BDTX $2.72
- PROF $6.24
- Average True Range (ATR)
- BDTX 0.18
- PROF 0.32
- MACD
- BDTX -0.00
- PROF -0.08
- Stochastic Oscillator
- BDTX 76.11
- PROF 11.44
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.